Roundhill Glp-1 & Weight Loss ETF OZEM
Set alert
30.57 USD -0.06 -0.18%
At close · Nov 2
30.57 0.00 -0.01%
After hours · Nov 2, 4:00 PM ET
30.49 Day range 30.70
28.34 52-week range 37.15
- YTD
- -10.50%
- 1 year
- +6.46%
- Open
- 30.50
- Prev close
- 30.63
- Mkt cap
- 39.44M
- Vol
- 10.01K
- Avg vol
- 15.25K
- EPS
- 1.66
- P/E
- 18.38
- Div yield
- 0.00%
More statistics
- Low
- 30.49
- High
- 30.70
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 26.99
- 200-d avg
- 27.14
2Y chart
Events in this range
- Dec 30, 2024Dividend: 0.05307
- Dec 30, 2025Dividend: 0.40991
Signals (102)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 5, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
Newest 20 of 102.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.66
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 26.99
- 200-day average
- 27.14
About Roundhill Glp-1 & Weight Loss ETF
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
News
- Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss
- Bet on This New GLP-1 ETF to Gain Exposure to a Booming Market
- Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Stock Price Down 0.6% – Time to Sell?
- From Laggard to Leader: The Surprising Comeback of Healthcare
- Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win
- Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Shares Down 0.4% – Time to Sell?
- Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
- Healthcare ETFs: From Broad Exposure to Big Breakthroughs
- Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
- GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
Your note
Sign in to keep a note on OZEM — it syncs with the Stock Master app.